This was the stock's seventh consecutive day of losses.

This comprehensive analysis examines Cigna's current position, future prospects, and the factors influencing its stock performance. advertisement. Investing.com. Cigna's SWOT analysis: ...

UnitedHealth Group Incorporated UNH and The Cigna Group CI are two leading players in U.S. managed care insurance, offering ...

This analysis is based on information available up to May 27, 2025, and reflects the most recent analyst reports and company performance data provided. For comprehensive insights into Cigna’s ...

11 analysts have shared their evaluations of Cigna (NYSE:CI) during the recent three months, expressing a mix of bullish and bearish perspectives.Summarizing their recent assessments, the table ...

InvestingPro offers 14 additional key tips about Cigna’s performance and prospects. The medical loss ratio (MLR) for the first quarter of 2025 stood at 82.2%, approximately 80 basis points ...

CVS Stock is an Outperformer Compared to CI & S&P 500 Year to date, CVS Health shares have surged 39.7%, significantly outpacing both Cigna’s 14.7% gain and the S&P 500’s 1.3% decline.

Cigna Not Pursuing Humana Merger, Stock Soars On Monday, Cigna Group (NYSE: CI ) said its officials are expected to participate in meetings with investors and analysts over the next several weeks .

Cigna’s stock leads selloff among drug middlemen on breakup fears — but this analyst says it’s not a real risk Last Updated: Dec. 12, 2024 at 7:22 a.m. ET First Published: Dec. 11, 2024 at 2 ...

Cigna’s SWOT analysis: ... Recent Financial Performance. Cigna’s financial results have been a mixed bag in recent ... You can also see if CI appears on our undervalued or overvalued stock lists.

Cigna's stock leads selloff among drug middlemen on breakup fears - but this analyst says it's not a real risk Provided by Dow Jones Dec 12, 2024, 12:22:00 PM By Ciara Linnane ...